Single-Row Versus Double-Row Repair for Achilles Insertional Tendinopathy (STRIDE)

January 6, 2026 updated by: Sam Park, Women's College Hospital

Single-Row Versus Double-Row Repair in the Surgical Management of Achilles Insertional Tendinopathy: A Randomized Controlled Trial (STRIDE Trial)

Achilles insertional tendinopathy may require surgical debridement and tendon reattachment when non-operative treatment fails. Single-row and double-row repairs are used, with biomechanical studies favoring double-row, but clinical evidence of improved outcomes is lacking and costs are higher. This multi-center randomized trial will use the VISA-A score to compare outcomes and inform cost-effective, evidence-based surgical care.

Study Overview

Detailed Description

Double-row repairs for Achilles insertional tendinopathy have been shown biomechanically to be stronger than single-row repairs, but clinical studies have not demonstrated clear advantages. Existing comparative studies are limited by retrospective designs and use of non-validated outcome measures such as AOFAS, VAS, and SF-36 Physical Function. No prospective randomized trials have evaluated clinical outcomes of single-row versus double-row repairs.

This multi-center randomized controlled trial will use the disease-specific Victorian Institute of Sports Assessment-Achilles (VISA-A) score to compare clinical outcomes between single-row and double-row repairs, providing high-quality evidence to guide optimal surgical management.

Study Type

Interventional

Enrollment (Estimated)

166

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5S 1B2
        • Women's College Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Must be deemed to have capacity to provide informed consent;
  2. Must sign and date the informed consent form;
  3. Stated willingness to comply with all study procedures;
  4. Adult patients between the ages of 18 and 75 years with symptomatic chronic Achilles insertional tendinopathy for a minimum of 3 months
  5. Failure of non-operative management (which includes physiotherapy, stretching exercises, heel lifts, nonsteroidal anti-inflammatory drugs (NSAIDs), activity modification, etc.) for at least 3 months.
  6. Preoperative imaging (x-ray and Medical Resonance Imaging (MRI)) is available and completed;
  7. Willingness of patients to follow the postoperative rehabilitation protocol;
  8. Willingness of patients to be available for follow up appointments for up to 2 years.

Exclusion Criteria:

  1. Non-insertional Achilles tendinopathy;
  2. Achilles tendon rupture;
  3. Previous Achilles tendon surgery;
  4. Oral steroid use or steroid injection within 3 months of surgery;
  5. History of connective tissue or collagen disorder (e.g. Marfan Syndrome)
  6. History of chronic inflammatory disorders
  7. History of neurological disease (stroke, cerebral palsy)
  8. History of using more than 30mg of oxycodone or equivalent per day;
  9. Current cigarette smoker (Former smokers must have quit for minimum of one year)
  10. Diabetes type I or II
  11. Pregnancy
  12. Hypersensitivity to metal, Polylactic Acid (PLA), or Polyetheretherketone (PEEK) materials
  13. Active infection
  14. Worker's compensation claim (e.g. WSIB)
  15. History of cognitive or mental health conditions that would make the participant unable to complete study procedures
  16. Non-English speaking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Single-row repair Arm
Single-row repair will involve 2 suture anchors (2 anchors total)
single-row (2 anchors)
Active Comparator: Double-row repair Arm
Double-row repair will involve 2 suture anchors for the proximal row and 2 suture anchors for the distal row (4 anchors total)
double-row (4 anchors)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disease-specific outcomes
Time Frame: 24 months after surgery
The Victorian Institute of Sport Assessment-Achilles (VISA-A) questionnaire is a validated, self-reported outcome measure designed to assess the severity of Achilles tendinopathy. It evaluates three key domains: pain, function, and activity level and produces a score from 0 to 100, with higher scores indicating better function and fewer symptoms.
24 months after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surgical Cost
Time Frame: Within 2 hours of surgery
Assess the cost difference between single-row repair versus double-row repair
Within 2 hours of surgery
Foot and Ankle Ability Measure (FAAM)
Time Frame: 24 months after surgery

The FAAM is a patient-reported outcome questionnaire designed to assess physical function in individuals with foot and ankle disorders.

Scores are typically expressed as percentages, with higher scores indicating better function.

24 months after surgery
Visual Analogue Scale Foot and ankle (VAS-FA)
Time Frame: 24 months after surgery
The VAS-FA is a patient-reported outcome measure designed to assess pain, function, and other symptoms related to foot and ankle disorders. It uses a visual analogue scale, typically a 100 mm line, where patients indicate the severity of their symptoms. Higher scores usually indicate better function or less pain.
24 months after surgery
Plantarflexion strength
Time Frame: 24 months after surgery

Measured using a HUMAC Norm Isokinetic Dynamometer Weakness: May indicate calf muscle atrophy, nerve injury, or Achilles tendon dysfunction.

Deficits: Can cause altered gait, decreased push-off, and balance problems.

24 months after surgery
Biomechanical performance
Time Frame: 24 months after surgery

Including ankle kinematics and kinetics during gait and functional tasks, assessed through markerless motion tracking.

Gait Analysis: Evaluating walking or running patterns in patients with musculoskeletal or neurological impairments.

24 months after surgery
Functional endurance
Time Frame: 24 months after surgery

As measured by the Heel Rise Test

Normal: Able to perform ≥25-30 single-leg heel raises with minimal fatigue. Weakness: Fewer repetitions or lower heel height may suggest calf muscle weakness.

24 months after surgery
Surgical Time
Time Frame: During surgery
Assess the operative time required for single-row repair versus double-row repair.
During surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Si-Hyeong Sam Park, MD, FRCPC, Women's College Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 1, 2026

Primary Completion (Estimated)

February 1, 2028

Study Completion (Estimated)

March 1, 2030

Study Registration Dates

First Submitted

November 28, 2025

First Submitted That Met QC Criteria

December 31, 2025

First Posted (Estimated)

January 7, 2026

Study Record Updates

Last Update Posted (Actual)

January 8, 2026

Last Update Submitted That Met QC Criteria

January 6, 2026

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • CTO Study Number:5686

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Achilles Tendinopathy

Subscribe